Stereotactic ablative radiotherapy for early stage lung cancer and lung metastases in a New Zealand population.

Aim: Stereotactic ablative radiotherapy (SABR) involves the delivery of high doses of precisely targeted radiation in a shorter time period than conventional radiotherapy. The aim of this study was to compare the outcomes of lung-based SABR in a New Zealand cohort to the global literature.

Methods: A single-institution retrospective analysis was performed on all patients who received lung-based SABR between May 2015 and September 2019 at Waikato Hospital, New Zealand.

A prospective feasibility study of MammoSite accelerated partial breast irradiation for early breast Cancer.

Background: Accelerated partial breast irradiation is a potential alternative to standard whole breast irradiation, following breast-conserving surgery, in the management of breast cancer. The MammoSite applicator-based technique allows for the delivery of a higher dose of radiation to the tumour bed and adjacent area, over a shorter treatment period.

Aims: To investigate the long-term feasibility of the MammoSite technique in early stage breast cancer in an Irish cohort.